This article first appeared on GuruFocus .
Release Date: November 13, 2025
For the complete transcript of the earnings call, please refer to the full earnings call transcript .
Positive Points
-
Centum Electronics Ltd ( BOM:517544 ) reported a robust standalone revenue growth of 18% year-on-year, driven by strong execution in the build-to-spec business for domestic defense and space customers.
-
EBITDA margins improved by 154 basis points to 11.97% in the second quarter, reflecting operational efficiency and an improved revenue mix.
-
The company has strengthened strategic partnerships, signing MOUs with GRSE and BEL to advance indigenous defense electronics and navigation systems.
-
Centum Electronics Ltd received NABL accreditation for its BTS unit, enhancing credibility in defense contracts.
-
The company maintains a healthy cash balance of 136 crores, which includes proceeds from a QIP, and has reduced some subsidiary borrowings.
Negative Points
-
Consolidated margins were impacted by subsidiary losses, with international operations facing headwinds due to weak macroeconomic conditions and intense competition in the European market.
-
The European subsidiary has not seen the expected uptake in demand, with delays in new project designs and increased competition leading to margin pressures.
-
The company is in the process of divesting or closing its Canadian operations, which have been a significant contributor to subsidiary losses.
-
Inventory levels have increased by 40-45%, primarily due to existing orders, which may indicate potential cash flow challenges if not managed properly.
-
The consolidated EBITDA declined by 12% year-on-year, with margins decreasing by 165 basis points to 6.16%, highlighting challenges in achieving profitability at the group level.
Q & A Highlights
-
Warning! GuruFocus has detected 3 Warning Signs with BOM:517544.
-
Is BOM:517544 fairly valued? Test your thesis with our free DCF calculator.
Q: On a consolidated level, our margins have dropped. When are we going to see our subsidiary become EBITDA positive? A: (Joint Managing Director) The subsidiaries are a high priority. We are confident of resolving the situation with our Canada operations soon, potentially by the end of the quarter. For our European operations, we are evaluating strategic options and expect to have a direction by the end of Q4. Our objective is to eliminate subsidiary losses impacting our overall numbers in the next financial year.
Q: Can you provide revenue and margin guidance for FY26 and FY27? A: (Joint Managing Director) Standalone numbers have been strong, with a 25% growth in the first half. We are targeting a 30% growth for the full financial year. For EBITDA margins, we expect to be in the range of 13% to 15% on a standalone basis by the end of the financial year.
Q: Our BTS business order book has slightly decreased from last year. What is the outlook for this business over the next 2-3 years? A: (Joint Managing Director) We expect strong order bookings in the second half of the year, with several programs in advanced stages. Over a 3-year period, we are targeting over 2000 crores of order bookings in this business.
Q: How do you see the EMS business over the next 2-3 years? A: (Joint Managing Director) We expect strong growth this year, driven by new customer additions now in production. We have a healthy pipeline and are targeting a 30% growth rate in the overall standalone business.
Q: Regarding the inventory increase, is it due to existing orders or a positive indication for expected order book growth? A: (CFO) The inventory increase is primarily for existing orders in both BTS and EMS divisions, supporting the expected revenue ramp-up in the second half of the year. All inventory is bought against firm purchase orders or customer forecasts.
For the complete transcript of the earnings call, please refer to the full earnings call transcript .
